A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Public ClinicalTrials.gov record NCT06298565. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT06298565
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- argenx
- Industry
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Interventions
- efgartigimod Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2024
- Primary completion
- May 31, 2034
- Completion
- May 31, 2034
- Last update posted
- Feb 16, 2026
2024 – 2034
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center, | San Francisco | California | 94143 | Recruiting |
| SFM Clinical Research, LLC | Boca Raton | Florida | 33487 | Recruiting |
| University of Florida College of Medicine Jacksonville | Jacksonville Beach | Florida | 32209 | Recruiting |
| Medsol Clinical Research Center Inc | Port Charlotte | Florida | 33952 | Recruiting |
| BayCare Health System, Inc. St Anthony's Hospital | St. Petersburg | Florida | 33705 | Recruiting |
| Prairie Education and Research Cooperative and HSHS Medical Group | O'Fallon | Illinois | 62701 | Recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Recruiting |
| Norton Neuroscience Institute | Louisville | Kentucky | 40241 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | Recruiting |
| Henry Ford Health System | Detroit | Michigan | 48202 | Recruiting |
| Oregon Health and Science University | Portland | Oregon | 97239 | Recruiting |
| University of Colorado Hospital | Portland | Oregon | 97239 | Recruiting |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Recruiting |
| National Neuromuscular Research Institute | Austin | Texas | 78759 | Recruiting |
| BCN Research, LLC - Gamma Therapeutic Center | Greenfield | Wisconsin | 53228 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06298565, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06298565 live on ClinicalTrials.gov.